Congressional committees have held several hearings this week on health policy issues. On March 24, the Energy and Commerce Health Subcommittee held a hearing on the 340B drug pricing program. Also on March 24, the House Ways and Means Subcommittee on Oversight examined CMS's use of the Fraud Prevention System (FPS) to identify and stop Medicare fraud, and the Senate Health, Education, Labor and Pensions Committee held a hearing entitled "Continuing America's Leadership: Advancing Research and Development for Patients." On March 25, the Senate Special Committee on Aging examined "The Fight Against Alzheimer's Disease: Are We on Track to a Treatment by 2025."
This article is presented for informational purposes only and is not intended to constitute legal advice.